Today We Are Closer To Measurably Improving Patient Lives

When I was 12 years old, I came home from school to learn that my father was diagnosed with a rare form of cancer. Later in life, I learned he had been misdiagnosed, and if it wasn’t for his gut feeling that the doctor was wrong, he wouldn’t be here with us today.

When it comes to their health, Americans don’t ask for second opinions enough. According to a poll from Harvard Medical School, 70% feel they don’t need to. If Americans aren’t compelled to get second opinions, we need to improve the initial care they receive. But how?

I dedicated the last decade to this charge. I got hands-on with clinical data and Memorial Sloan Kettering, built industry-first healthcare technology at DeepIntent, and strategized solutions to measurably improve patient lives.

Today, I have the answer.

It brings me great pleasure to announce the official launch of DeepIntent’s Patient Modeled Audiences. Our brilliant team of strategists, engineers, and data scientists have succeeded in developing a privacy-first, artificial intelligence (AI) solution that connects patients with the important and timely information they need to make better decisions about their health.

Patient Modeled Audiences combines emerging privacy technologies – like differential privacy – with artificial intelligence to build powerful advertising audiences based on social determinants. These precise, HIPAA-certified patient audiences have been rigorously tested in a closed beta that included a diverse cross-section of therapeutic categories and campaign goals. Our approach has been recognized by all 10 client participants as being a top performer – and in most cases, the best performer – among dozens of competing solutions.

In one case study, our audience placed 1st among 12 other data providers, yielding 25% higher Audience Quality and almost 60% higher efficiency on cost-per-treating-patient.

These results prove that the balance between privacy and performance is not zero-sum. With DeepIntent’s technology at the foundation, critical insights can be extracted from sensitive data while ensuring the utmost patient privacy. In turn, our clients will better identify patients in need, and share information that will drive better health outcomes. 

This endeavor represents the hard work of various teams within DeepIntent and across our strategic partners. Collectively, we committed more than a year to design, implement, and certify Patient Modeled Audiences. Today is a significant victory – not just for our company and our partners, but for patients. When we arm patients with the information they need to make informed decisions about their health, we will save lives.

Read more – Chris sat down with Business Insider to dive deeper on our privacy-safe AI, and using de-identified health data to improve ad efficiency and efficacy

More Insights

Amit Chaturvedi
Blog Post
Orchestrating Client and Company Success at DeepIntent
If you think about an orchestra, there are string instruments, wind instruments, percussionists, vocalists, and so on. Like most teams, the orchestra is comprised of...
Read More
Blog Post
Living in the Cookieless Present: Q+A with ID5 Chief Strategy Officer Joanna Burton
With Google on track to deprecate third-party cookies in Chrome in 2024, marketers are getting ready for the cookieless future. But as Joanna Burton —...
Read More
DeepIntent and Matterkind case study: Measuring pharma ad campaigns, proving CTV superiority
Blog Post
How DeepIntent and Matterkind Proved CTV’s Superiority for Measuring Pharma ad Campaigns, Delivering 2X Higher NBRx
The pharmaceutical industry has long favored broadcast television. In fact, linear TV accounted for more than 70% of last year’s ad spend. That’s because linear...
Read More
Back to Top